ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

biotech

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Over the years biotech investors who have owned the right stocks have made some very big money on Federal Drug Administration (FDA) approval of leading drug candidates. Typically biotech firms ...
Read Full Story »
Bull and Bear figures

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

U.S. equity markets opened higher this morning following some mixed economic data released in China. The country’s CPI rose less than expected, producer prices fell, fixed asset investment rose a ...
Read Full Story »
stock symbol ticker

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

Here are today’s five biggest gaining stocks at closing: ACADIA Pharmaceuticals inc. (NASDAQ: ACAD) is up 64.4% at $13.10. Rite Aid Corp. (NYSE: RAD) is up 18.4% at $2.12. Metalico ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — April 11, 2013: Markets Mostly Hold Early Gains (MSFT, ADBE, SLB, KRFT, UA, ADTN, BBBY, NG, PIR, LEDS, CRMB, RAD, ACAD, BBRY, HPQ)

U.S. equity markets opened flat to lower this morning following yesterday’s record-setting session. Economic data was minimal today. In Asia, machinery orders rose more than expected in Japan, but the ...
Read Full Story »
stock symbol ticker

Market Close: Big Winners & Losers for March 21, 2013 (ANAC, ACAD, ENTA, CMT, AFFY, BLDP, GMO, CIMT, AQ, SCHL)

Here are today’s five biggest gaining stocks at closing: Anacor Pharmaceuticals Inc. (NASDAQ: ANAC) is up 26% at $4.84. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is up 23.9% at $8.24. Enanta ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 21, 2013: Markets Slide on Europe Fears (FDX, WSM, YHOO, BKW, HON, ORCL, JBL, TUMI, KBH, LULU, MOV, ROST, MU, NKE, SLW, VRNG, DRI, TIF, AFFY, ACAD)

U.S. equity markets opened lower this morning and trailed slowly downward all day. The situation in Cyprus was unchanged this morning (more coverage here). In Europe, both manufacturing and non-manufacturing ...
Read Full Story »

24/7 Wall St. Closing Bell — November 27, 2012: Markets Falter Again (SHOO, BRCD, YELP, NOV, CVC, ADT, ADI, GMCR, PVH, AEO, ANN, EXPR, TFM, JASO, MOV, LEDS, RAH, CAG, ACAD, MMR)

U.S. equity markets opened lower again this morning, even following an agreement on the amount and delivery date of another eurozone bailout package for Greece (more coverage here). The lack ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is down Tuesday, with the Dow Jones Industrial Average down 0.24%, the Nasdaq down 0.26% and the S&P 500 down 0.23%. Today's winners include a pharmaceutical firm ...
Read Full Story »

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is proving to be the big winner of the day. In fact, it may be the winner of the month on any percentage gain in ...
Read Full Story »

BioHealth Business Daily (ACAD, AEN, DNDN, EXAS, ITMN, MIPI, OREX, OSIP, RNN, SLXP, VVUS)

We are seeing many news-related movers in today's edition of the BioHealth Business Daily.  ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona Pharmaceuticals, Inc. (AMEX: AEN), Dendreon Corporation (NASDAQ: DNDN), Exact Sciences ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (ACAD, ACE, AACC, RATE, GYMB, KIM, MMC, MVL, NCR, WSH)

These aren't all of the analyst calls out there today, but these are ten of the calls impacting shares early this Tuesday morning:ACADIA Pharmaceuticals (ACAD) Raised to Neutral at Banc ...
Read Full Story »

The 52-Week Low Club (PPC)(PBG)(RCL)(GHS)(ACAD)

Pilgrim's Pride (PPC) Downgraded by Credit Suisse. Down to $15.67 from 52-week high of $41.Pepsi Bottling Group (PBG) Still troubled by problems at one of Coke's bottlers. Down to $29.22 ...
Read Full Story »

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

If you thought biotech news was getting quiet going into earnings season, think again.Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on pimavanserin, a treatment  for Parkinson’s disease psychosis (PDP) ...
Read Full Story »

Pre-Market Analyst Calls (July 10, 2007)

ACAD started as Outperform at FBR.ALC started as Outperform at RBC.ARUN started as Buy at Jefferies.ATVI started as Buy at First Albany.AZ raised to Buy at UBS.CHA cut to Hold ...
Read Full Story »

Cramer Speculates in CV Therapeutics (CVTX)

On tonight's Mad Money on CNBC, Jim Cramer had his normal 'Speculation Friday' and talked CV Therapeutics (CVTX) for a speculative biotech in with Acadia (ACAD) and Nastech (NSTK).  Cramer ...
Read Full Story »